Tocqueville Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-27,100
| Closed | -$1.42M | – | 727 |
|
|
2020
Q3 | $1.42M | Sell |
27,100
-17,800
| -40% | -$737K | 0.03% | 345 |
|
|
2020
Q2 | $1.49M | Hold |
44,900
| – | – | 0.03% | 336 |
|
|
2020
Q1 | $1.22M | Sell |
44,900
-12,400
| -22% | -$345K | 0.03% | 328 |
|
|
2019
Q4 | $1.13M | Hold |
57,300
| – | – | 0.02% | 436 |
|
|
2019
Q3 | $743K | Sell |
57,300
-76,849
| -57% | -$928K | 0.01% | 497 |
|
|
2019
Q2 | $1.67M | Buy |
134,149
+7,750
| +6% | +$103K | 0.02% | 407 |
|
|
2019
Q1 | $1.84M | Buy |
126,399
+51,483
| +69% | +$658K | 0.02% | 395 |
|
|
2018
Q4 | $827K | Sell |
74,916
-455,750
| -86% | -$6.34M | 0.01% | 485 |
|
|
2018
Q3 | $14M | Sell |
530,666
-131,615
| -20% | -$3.56M | 0.18% | 151 |
|
|
2018
Q2 | $13.5M | Sell |
662,281
-123,210
| -16% | -$2.64M | 0.17% | 149 |
|
|
2018
Q1 | $14.3M | Sell |
785,491
-178,293
| -18% | -$2.97M | 0.18% | 148 |
|
|
2017
Q4 | $13.4M | Buy |
963,784
+683,296
| +244% | +$9.24M | 0.15% | 168 |
|
|
2017
Q3 | $5.19M | Buy |
280,488
+8,150
| +3% | +$136K | 0.06% | 305 |
|
|
2017
Q2 | $4.6M | Sell |
272,338
-3,430
| -1% | -$52.2K | 0.06% | 306 |
|
|
2017
Q1 | $3.68M | Buy |
275,768
+11,050
| +4% | +$173K | 0.04% | 344 |
|
|
2016
Q4 | $3.98M | Sell |
264,718
-27,542
| -9% | -$364K | 0.05% | 314 |
|
|
2016
Q3 | $3.42M | Buy |
292,260
+19,205
| +7% | +$226K | 0.04% | 347 |
|
|
2016
Q2 | $2.95M | Sell |
273,055
-43,550
| -14% | -$449K | 0.04% | 359 |
|
|
2016
Q1 | $2.92M | Sell |
316,605
-872,275
| -73% | -$9.39M | 0.04% | 340 |
|
|
2015
Q4 | $17.6M | Sell |
1,188,880
-425,837
| -26% | -$7.13M | 0.24% | 119 |
|
|
2015
Q3 | $26.5M | Sell |
1,614,717
-37,345
| -2% | -$764K | 0.35% | 81 |
|
|
2015
Q2 | $37.7M | Sell |
1,652,062
-21,396
| -1% | -$426K | 0.44% | 60 |
|
|
2015
Q1 | $25.4M | Buy |
1,673,458
+353,750
| +27% | +$4.6M | 0.3% | 105 |
|
|
2014
Q4 | $15.9M | Buy |
1,319,708
+1,269,708
| +2,539% | +$14.5M | 0.17% | 154 |
|
|
2014
Q3 | $567K | Hold |
50,000
| – | – | 0.01% | 586 |
|
|
2014
Q2 | $604K | Buy |
50,000
+10,000
| +25% | +$118K | 0.01% | 673 |
|
|
2014
Q1 | $466K | Buy |
40,000
+7,000
| +21% | +$119K | 0.01% | 593 |
|
|
2013
Q4 | $583K | Hold |
33,000
| – | – | 0.01% | 548 |
|
|
2013
Q3 | $475K | Buy |
33,000
+8,000
| +32% | +$122K | 0.01% | 653 |
|
|
2013
Q2 | $377K | Buy |
+25,000
| New | +$330K | 0.01% | 709 |
|
Tocqueville Asset Management's MNTA Position: Q4 2020 in Review
Tocqueville Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 27,100 shares — an estimated $1.42M sold.
Tocqueville Asset Management first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $37.7M in Q2 2015. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Tocqueville Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Tocqueville Asset Management sold 27,100 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.42M.
- Tocqueville Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Tocqueville Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $37.7M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Tocqueville Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.